BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23790260)

  • 1. Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders.
    Kuehne LK; Reiber H; Bechter K; Hagberg L; Fuchs D
    J Psychiatr Res; 2013 Oct; 47(10):1417-22. PubMed ID: 23790260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.
    Bechter K; Reiber H; Herzog S; Fuchs D; Tumani H; Maxeiner HG
    J Psychiatr Res; 2010 Apr; 44(5):321-30. PubMed ID: 19796773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kuehne LK, Reiber H, Bechter K, Hagberg L, Fuchs D., Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. Journal of Psychiatric Research, Volume 47, Issue 10, October 2013, pages 1417-1422.
    Ghisoni K; Latini A
    J Psychiatr Res; 2015 Apr; 63():141-2. PubMed ID: 25749244
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.
    Castellazzi M; Morotti A; Tamborino C; Alessi F; Pilotto S; Baldi E; Caniatti LM; Trentini A; Casetta I; Granieri E; Pugliatti M; Fainardi E; Bellini T
    Fluids Barriers CNS; 2020 Feb; 17(1):14. PubMed ID: 32024544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neopterin and macrophage inflammatory protein-1alpha in the cerebrospinal fluid of schizophrenic patients: no evidence of intrathecal inflammation.
    Nikkilä HV; Ahokas A; Wahlbeck K; Rimón R; Andersson LC
    Neuropsychobiology; 2002; 46(4):169-72. PubMed ID: 12566931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis.
    Meixensberger S; Bechter K; Dersch R; Feige B; Maier S; Schiele MA; Runge K; Denzel D; Nickel K; Spieler D; Urbach H; Prüss H; Domschke K; Tebartz van Elst L; Endres D
    Fluids Barriers CNS; 2020 Nov; 17(1):67. PubMed ID: 33176794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
    Reiber H
    J Neurol Sci; 1994 Apr; 122(2):189-203. PubMed ID: 8021703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What determines the CSF concentrations of albumin and plasma-derived IgG?
    Seyfert S; Faulstich A; Marx P
    J Neurol Sci; 2004 Apr; 219(1-2):31-3. PubMed ID: 15050434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity.
    Hegen H; Auer M; Zeileis A; Deisenhammer F
    Clin Chem Lab Med; 2016 Feb; 54(2):285-92. PubMed ID: 26079822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein.
    Reiber H; Padilla-Docal B; Jensenius JC; Dorta-Contreras AJ
    Fluids Barriers CNS; 2012 Aug; 9(1):17. PubMed ID: 22889364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases.
    Steinacker P; Weidehaas K; Cepek L; Feneberg E; Kretzschmar HA; Otto M
    Acta Neurol Scand; 2013 Oct; 128(4):249-56. PubMed ID: 23510454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the blood-CSF barrier altered in disease?
    Seyfert S; Faulstich A
    Acta Neurol Scand; 2003 Oct; 108(4):252-6. PubMed ID: 12956858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.
    Kirch DG; Alexander RC; Suddath RL; Papadopoulos NM; Kaufmann CA; Daniel DG; Wyatt RJ
    J Neural Transm Gen Sect; 1992; 89(3):219-32. PubMed ID: 1389005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels.
    Andersson LM; Hagberg L; Fuchs D; Svennerholm B; Gisslén M
    J Neurovirol; 2001 Dec; 7(6):542-7. PubMed ID: 11704886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation.
    Dale RC; Brilot F; Fagan E; Earl J
    Dev Med Child Neurol; 2009 Apr; 51(4):317-23. PubMed ID: 19191826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid.
    Seyfert S; Quill S; Faulstich A
    Clin Chem Lab Med; 2009; 47(8):955-8. PubMed ID: 19548846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology.
    Müller N; Ackenheil M
    Schizophr Res; 1995 Feb; 14(3):223-8. PubMed ID: 7766533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
    Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
    Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
    Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S
    J Neurovirol; 2016 Feb; 22(1):88-92. PubMed ID: 26246357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
    Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
    Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.